27 completed, 11 terminated, 3 unknown, 2 withdrawn. 44 Phase 3, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 44 | Completed 27, Terminated 11, Unknown 3, Withdrawn 2, Active not recruiting 1 |
| Phase 2 | 5 | Completed 3, Terminated 1, Unknown 1 |
Follow cellcept: new trials by email Literature Review of cellcept trials Research Report on cellcept
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome Biospecimen Collection, Bone Marrow Aspiration, Busulfan - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 3 | Active not recruiting | Children's Oncology Group | 66 | 2023-03-15 | 2026-07-30 |
| Outcomes of Patients After Allo-HSCT With Decitabine and NAC decitabine, Acetylcysteine, Semustine - Engraft Failure, Relapse | Phase 3 | Unknown | The First Affiliated Hospital of Soochow University | 100 | 2021-07-01 | 2021-06-30 |
| Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression Cyclophosphamide, Fludarabine, Total Body Irradiation - Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia | Phase 3 | Completed | Dartmouth-Hitchcock Medical Center | 21 | 2018-03-28 | 2026-07-17 |
| Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score Everolimus, Tacrolimus, Mycophenolate Mofetil - Pediatric Heart Transplantation, Immunosuppression | Phase 3 | Completed | Boston Children's Hospital | 211 | 2018-01-29 | 2026-07-31 |
| Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune Thrombocytopenia Rituximab, Dexamethasone, Mycophenolate mofetil - Immune Thrombocytopenia | Phase 3 | Withdrawn | Weill Medical College of Cornell University | 2016-12-01 | 2018-08-14 | |
| De Novo Everolimus Versus Tacrolimus in Combination With Mofetil Mycophenolate and Low Dose Corticosteroids to Reduce Tacrolimus Induced Nephrotoxicity in Liver Transplantation: a Prospective, Multicentric, Randomised Study Tacrolimus, Everolimus, Mycophenolate mofetil - Liver Transplantation | Phase 3 | Withdrawn | Rennes University Hospital | 2016-11-01 | 2022-12-14 | |
| Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Nephritis Tacrolimus, Mycophenolate mofetil - Lupus Nephritis | Phase 3 | Completed | The University of Hong Kong | 130 | 2015-12-05 | 2025-09-25 |
| Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus Nephritis Oral prednisolone, Rituximab, Mycophenolate mofetil - Systemic Lupus Erythematosus, Lupus Nephritis | Phase 3 | Terminated | Imperial College London | 24 | 2015-04-01 | 2018-02-01 |
| Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention tacrolimus, methotrexate, Mycophenolate mofetil - Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia | Phase 3 | Completed | Case Comprehensive Cancer Center | 101 | 2014-07-07 | 2023-09-11 |
| Methotrexate and Mycophenolate Mofetil for UVEITIS Mycophenolate mofetil, Methotrexate, Prednisone - Uveitis | Phase 3 | Completed | University of California, San Francisco | 216 | 2013-08-01 | 2024-04-02 |
| Belatacept Therapy for the Failing Renal Allograft Belatacept, Calcineurin inhibitor therapy, Mycophenolate mofetil - Failing Renal Allograft | Phase 3 | Completed | Andrew B Adams | 13 | 2013-08-01 | 2021-01-26 |
| A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys Everolimus, Tacrolimus, Mycophenolate mofetil (MMF/MPA) - Delayed Graft Function | Phase 2 / Phase 3 | Terminated | Matthew Cooper | 25 | 2013-06-01 | 2019-04-26 |
| Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis BMS-188667, Mycophenolate mofetil, Prednisone - Lupus Nephritis | Phase 3 | Terminated | Bristol-Myers Squibb | 695 | 2013-01-22 | 2021-02-26 |
| Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression Tacrolimus and MMF. - Graft Versus Host Disease | Phase 3 | Unknown | Colorado Blood Cancer Institute | 50 | 2010-11-01 | 2014-07-01 |
| Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant Allogeneic Hematopoietic Stem Cell Transplantation, Cyclosporine, Fludarabine Phosphate - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 3 | Completed | Fred Hutchinson Cancer Center | 174 | 2010-11-01 | 2026-04-30 |
| First-line Antimetabolites as Steroid-sparing Treatment Uveitis Pilot Trial Methotrexate, Mycophenolate mofetil - Uveitis | Phase 3 | Completed | University of California, San Francisco | 80 | 2010-10-01 | 2016-07-15 |
| A Study of Mycophenolate Mofetil (CellCept) in Lung Transplant Recipients mycophenolate mofetil - Lung Transplantation | Phase 3 | Completed | Hoffmann-La Roche | 68 | 2010-01-01 | 2017-02-10 |
| Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts tacrolimus, Simulect, Cellcept - Kidney Transplantation | Phase 3 | Completed | Astellas Pharma Inc | 281 | 2009-08-17 | 2024-11-01 |
| Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma Sirolimus, Methotrexate, Tacrolimus - Non-hodgkin Lymphoma, Hodgkin Lymphoma | Phase 3 | Completed | Dana-Farber Cancer Institute | 139 | 2009-06-01 | 2019-02-01 |
| Concentration-controlled Therapy of Mycophenolate Mofetil (MMF) in Proliferative Lupus Nephritis Mycophenolate mofetil - Lupus Nephritis | Phase 3 | Completed | Chulalongkorn University | 24 | 2009-05-01 | 2013-09-30 |
Showing 20 of 44. Sign in to see all of them.
Lupus Nephritis (8) · Leukemia, Myeloid, Acute (6) · Leukemia, Lymphocytic, Chronic, B-Cell (5) · Myeloproliferative Disorders (5) · Hodgkin Disease (4) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (4) · Lymphoma, Non-Hodgkin (4) · Multiple Myeloma (4) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (4) · Graft vs Host Disease (3) · Lymphoma, Large B-Cell, Diffuse (3) · Lymphoma, Mantle-Cell (3) · Myelodysplastic Syndromes (3) · Hematologic Neoplasms (2) · Hyperlipoproteinemia Type I (2)
Hoffmann-La Roche (8) · Astellas Pharma Inc (3) · Fred Hutchinson Cancer Center (3) · Amsterdam Molecular Therapeutics (2) · Chulalongkorn University (2) · Rennes University Hospital (2) · University of California, San Francisco (2) · Andrew B Adams (1) · Boston Children's Hospital (1) · Bristol-Myers Squibb (1) · Cambridge University Hospitals NHS Foundation Trust (1) · Case Comprehensive Cancer Center (1) · Children's Oncology Group (1) · Colorado Blood Cancer Institute (1) · Dana-Farber Cancer Institute (1)
United States (19) · Canada (10) · Germany (7) · Australia (4) · China (4) · Czechia (4) · France (4) · Italy (4) · India (3) · Mexico (3) · United Kingdom (3) · Argentina (2) · Brazil (2) · Hong Kong (2) · Hungary (2)
Brenda Sandmaier (2) · Andreas A Schnitzbauer, MD (1) · Andrew B Adams, MD, PhD (1) · Bart Scott (1) · Betty Hamilton, MD (1) · Christopher S Almond, MD, MPH (1) · Daniel Gaudet, MD, Ph.D. (1) · David Burks, MD (1) · David Jayne (1) · Eric Bellissant, MD, PhD (1) · Hans J Schlitt, MD (1) · Harris Foster, MD (1)
PMID 32499241, PMID 19270260, PMID 19933596, PMID 20039429, PMID 20498245, PMID 20840760, PMID 21080348, PMID 22087680, PMID 22231479, PMID 22438229, PMID 22717743, PMID 22922564, PMID 26018348, PMID 26729448, PMID 26867033, PMID 28414043, PMID 30089664, PMID 30582281, PMID 30612116, PMID 31248843, PMID 31503307, PMID 32779952, PMID 33315277, PMID 33675850, PMID 35085661, PMID 35143800, PMID 36701644, PMID 36749914, PMID 37294447, PMID 37352262, PMID 38299639, PMID 38864363, PMID 39082471, PMID 39190826, PMID 39739990, PMID 40960806, PMID 41241398, PMID 42805336
P01CA018029 (2), P01CA078902 (2), P30CA015704 (2), 2009 (1), K23HL084054 (1), P01HL036444 (1), U10CA180886 (1), U10EY021125 (1)